Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArcontech Group Regulatory News (ARC)

Share Price Information for Arcontech Group (ARC)

Share Price is delayed by 15 minutes
Get Live Data
83.50    6.00 (7.74%)
Bid:
82.00
Ask:
85.00
Spread: 3.00 (3.659%)
Market Cap: £11.17m
ARC Live PriceLast checked at - London Stock Exchange

Intraday Arcontech Group Share Chart

Trading Statement

Today 07:00

RNS Number : 0392K
Arcontech Group PLC
29 June 2026
Β 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

ARCONTECH GROUP PLCΒ 

("Arcontech" or the "Company")

Client Win/Trading update

Arcontech (AIM: ARC), the provider of software products and services for the management of real-time financial market-data, is pleased to announce that it has secured a new contract for its CityVision real-time market data platform to enable multiple data sources to be consumed by various applications written in different programming languages.

Following a successful bidding process, Arcontech has signed a 3-year contract with a total value of approximately Β£800k with a major European bank for deployment of its software in various areas within its trading infrastructure. The contract is with a new customer and has strong expansion potential across the customer's wider market-data estate, with revenue recognition expected to commence in calendar Q3 2026.

As a vendor agnostic market data platform, Arcontech CityVision provides a cost-effective alternative to existing platforms and the flexibility to choose any source of data to avoid "vendor lock-in". Arcontech CityVision is relied upon by some of the largest global banks.

The Company would also like to advise that current performance for the full year ended 30 June 2026 for both revenue and profit is in line with market expectations.

Financial expectations noted above are preliminary and are subject to year-end and financial close and audit review processes.

Enquiries:

Arcontech Group plc 020 7256 2300

Geoff Wicks, Chairman and Non-Executive Director

Matthew Jeffs, Chief Executive

Cavendish Capital Markets Ltd (Nomad & Broker) 020 7220 0500

Jonny Franklin Adams/Isaac Hooper (Corporate Finance)

Harriet Ward (Corporate Broking)

To access more information on the Group please visit: www.arcontech.com

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBLGDLSXDDGLL
Date   Source Headline
8th Sep 20217:00 amRNSExercise of Options
7th Sep 20217:00 amRNSExercise of Options, Director/PDMR Shareholding
1st Sep 20214:41 pmRNSSecond Price Monitoring Extn
1st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSFinal Results
10th Aug 20217:00 amRNSNotice of Results
12th Mar 202112:16 pmRNSHolding(s) in Company
23rd Feb 20217:00 amRNSInterim Results
22nd Jan 20214:30 pmRNSIssue of Equity
16th Oct 20207:00 amRNSAgreement to upgrade longstanding Tier 1 Client
5th Oct 20203:03 pmRNSGrant of Options
2nd Oct 202011:05 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSNew client win to contribute data to Factset
29th Sep 202010:53 amRNSResult of AGM
10th Sep 20207:00 amRNSIssue of Equity & PDMR Shareholding
8th Sep 20207:00 amRNSPosting of Annual Report & Notice of AGM
2nd Sep 20207:00 amRNSFinal Results
27th Aug 20201:59 pmRNSNotice of Results
20th Jul 20207:00 amRNSBoard appointment
15th Jul 20207:00 amRNSTrading Update / Notice of Results
1st Jun 20207:00 amRNSDirectorate change & Appointment of CoSec
16th Mar 20204:40 pmRNSSecond Price Monitoring Extn
16th Mar 20204:36 pmRNSPrice Monitoring Extension
5th Mar 20207:00 amRNSInterim Results
28th Feb 20203:28 pmRNSTrading Update & Notice of Results
2nd Dec 20194:20 pmRNSMichael Levy
3rd Oct 20191:28 pmRNSResult of AGM
27th Sep 20191:14 pmRNSGrant of Options
11th Sep 20197:00 amRNSHolding(s) in Company
2nd Sep 20197:00 amRNSPosting of Annual Report & Notice of AGM
22nd Aug 20197:00 amRNSFinal Results
11th Jul 20197:00 amRNSTrading Update and Notice of Results
15th May 20197:00 amRNSDirector/PDMR Shareholding
8th May 20194:21 pmRNSHolding(s) in Company
29th Mar 20192:27 pmRNSDirector/PDMR Shareholding
27th Feb 20197:00 amRNSInterim Results
4th Feb 20197:00 amRNSIncreased client uptake of Excelerator
4th Dec 20189:56 amRNSHolding(s) in Company
3rd Dec 20184:13 pmRNSGrant of Options
27th Sep 201812:20 pmRNSResult of AGM
31st Aug 20187:00 amRNSPosting of Annual Report & Notice of AGM
23rd Aug 20187:00 amRNSFinal Results
13th Jul 20182:47 pmRNSDirector/PDMR Shareholding
10th Jul 20187:00 amRNSTrading Update / Notice of Results
20th Apr 20188:30 amRNSIssue of Equity and Director / PDMR Shareholding
29th Mar 20182:02 pmRNSDirector/PDMR Shareholding
1st Mar 201811:00 amRNSHolding(s) in Company
22nd Feb 20187:00 amRNSHalf-year Report
12th Oct 20173:32 pmRNSIssue of Equity & Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.